Table 6.
Different HPV subtype infection rates among NILM, ASC, LSIL, and HSIL, respectively
| HPV subtype | NILM (%) N = 19,493 |
ASC (%) N = 858 |
LSIL (%) N = 561 |
HSIL (%) N = 327 |
|---|---|---|---|---|
| HPV16 | 591 (3.03) | 130 (15.15) | 73 (13.01) | 148 (45.26) |
| HPV18 | 234 (1.20) | 46 (5.36) | 16 (2.85) | 16 (4.89) |
| HPV31 | 196 (1.01) | 33 (3.85) | 19 (3.39) | 16 (4.89) |
| HPV33 | 103 (0.53) | 26 (3.03) | 14 (2.50) | 12 (3.67) |
| HPV35 | 151 (0.77) | 26 (3.03) | 17 (3.03) | 11 (3.36) |
| HPV39 | 368 (1.89) | 68 (7.93) | 41 (7.31) | 13 (3.98) |
| HPV45 | 62 (0.32) | 16 (1.86) | 5 (0.89) | 3 (0.92) |
| HPV51 | 296 (1.52) | 79 (9.21) | 76 (13.54) | 14 (4.28) |
| HPV52 | 764 (3.92) | 131 (15.27) | 59 (10.52) | 32 (9.79) |
| HPV56 | 272 (1.40) | 57 (6.64) | 98 (17.47) | 8 (2.45) |
| HPV58 | 662 (3.40) | 132 (15.38) | 58 (10.34) | 57 (17.43) |
| HPV59 | 253 (1.30) | 39 (4.55) | 18 (3.21) | 6 (1.83) |
| HPV68 | 180 (0.92) | 46 (5.36) | 27 (4.81) | 5 (1.53) |
HPV human papillomavirus, NILM negative for intraepithelial lesions or malignancy, ASC atypical squamous cells, LSIL low grade squamous intraepithelial lesion, HSIL high grade squamous intraepithelial lesion